Multinationals

Expanding right into Europe

Innovation is the life source of Life Sciences. But strategic and meticulous planning is key to commercial success, especially when entering a new regional market.

What the US Tax Reform means for Expat Americans

On the 20th of December, President Trump hosted an array of Republican Congressmen and Congresswomen at the White House to celebrate the successful passage of the Tax Reform Bill, the most sweeping reform of the U.S. tax system in over 30 years.
11

Switzerland’s attractiveness for multinational corporations at risk

Multinational corporations are in permanent business transformation mode. Many of them have located key value drivers in Switzerland because of the country’s flexibility and stable business environment. But will Switzerland remain attractive as companies seek to transform their business towards fast and sustainable growth?
12

Smart Site Selection for Life Sciences Companies

Life science companies have to future-proof their value chain by placing functions, assets and risks in locations where they are planning to have their profits taxed. Structures where profit allocations are made in tax-beneficent locations with little or no substance are no longer viable.
8

Familienunternehmen zwischen Tradition und Innovation

Familienunternehmen gehören zu den häufigsten Organisationsformen der heutigen Geschäftswelt und sie sind eine treibende Kraft in der Weltwirtschaft. Auch in der Schweiz können rund 88% aller Unternehmen als Familienunternehmen bezeichnet werden. Was ist ihr Erfolgsrezept?
11

How attractive are European Life Sciences Sites?

KPMG’s newest report on leading Life Sciences Clusters in Europe, released on 3 November 2015 at the Bio Europe Congress, reveals important differences between different countries in Europe and their attractiveness for Foreign Direct Investments for the Life Sciences Industry.
16